or Try an Advanced Search...

    Technical Analysis for PTPI - Petros Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.43 -5.36% -0.02
    PTPI closed down 5.36 percent on Monday, July 1, 2024, on 29 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PTPI trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish -5.36%
    Wide Bands Range Expansion -5.36%
    Spinning Top Other -2.81%
    Wide Bands Range Expansion -2.81%
    Wide Bands Range Expansion -1.25%
    Gapped Down Weakness -1.25%
    20 DMA Resistance Bearish -9.79%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -9.79%
    Older End-of-Day Signals for PTPI ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 10 hours ago
    20 DMA Resistance about 10 hours ago
    Down 3% about 10 hours ago
    Rose Above 20 DMA about 10 hours ago
    Up 3% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PTPI Chart by TradingView
    Basic chart:

    Profile

    Petros is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to ED, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and chronic), hormone health and substance use disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Disease Disorders Dysfunction Chronic Condition Petros Men's Health Psychosocial Substance Use Disorder

    Is PTPI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 29 Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch
    May 14 Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
    May 14 Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
    May 3 Petros Pharmaceuticals files $100M mixed securities shelf
    Apr 25 Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
    Apr 23 Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
    Apr 16 Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
    Apr 2 Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 2 Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
    Mar 19 Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider
    See more PTPI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.74
    52 Week Low 0.385
    Average Volume 351,422
    200-Day Moving Average 1.18
    50-Day Moving Average 0.57
    20-Day Moving Average 0.46
    10-Day Moving Average 0.44
    Average True Range 0.06
    RSI (14) 40.48
    ADX 15.65
    +DI 20.52
    -DI 19.96
    Chandelier Exit (Long, 3 ATRs) 0.48
    Chandelier Exit (Short, 3 ATRs) 0.56
    Upper Bollinger Bands 0.53
    Lower Bollinger Band 0.39
    Percent B (%b) 0.32
    BandWidth 32.37
    MACD Line -0.05
    MACD Signal Line -0.05
    MACD Histogram 0.0094
    Fundamentals Value
    Market Cap 953.06 Thousand
    Num Shares 2.2 Million
    EPS -6.21
    Price-to-Earnings (P/E) Ratio -0.07
    Price-to-Sales 0.44
    Price-to-Book 0.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.50
    Resistance 3 (R3) 0.51 0.50 0.49
    Resistance 2 (R2) 0.50 0.48 0.49 0.49
    Resistance 1 (R1) 0.46 0.47 0.46 0.46 0.48
    Pivot Point 0.45 0.45 0.44 0.44 0.45
    Support 1 (S1) 0.42 0.43 0.41 0.41 0.38
    Support 2 (S2) 0.40 0.42 0.40 0.38
    Support 3 (S3) 0.37 0.40 0.37
    Support 4 (S4) 0.36